|
Category: Intellectual Property Rights & Innovation
[Forum] [Spotlight] [Commentary] [Research] [Events] [News]
Forum
Commentary
- The Thai Flu Wall Street Journal, 3-14-07
- Thai Patent Turmoil by Ron Cass, Wall Street Journal Asia, 3-12-07
- Bangkok's Drug War Goes Global Wall Street Journal, 3-7-07
- 40 Years Later, Still No Cure by Phyllis Richman, Washington Post, 3-7-07
- India and the Drug Patent Wars by Roger Bate, AEI Online, 2-7-07
- Drugs in Thailand: The government should take care about ripping up patents Financial Times, 1-31-07
- Science and Shams by David Shaywitz, The Boston Globe, 7-27-06
- Plundering Patents by Alan Oxley, Wall Street Journal Europe, 2-1-06
- A rebuttal on ‘half-truths’ by Robert Goldberg, Ph.D., Washington Times, 7-8-05
- Misdiagnosing the diseases of the poor by Barun Mitra, International Policy Network, 2-9-05
- Intellectual Property and Its Discontents Washington Times, 10-14-04
- Are Free-Trade Agreements Good for Your Health? by Benedict Irvine, by Andres Mejia-Vergnaud, Wall Street Journal Asia, 9-10-04
- Biotech Destruction by Robert Goldberg, Ph.D., Tech Central Station, 4-30-04
- Borking Mark McClellan by Robert Goldberg, Ph.D., Washington Times, 3-8-04
- Drugs from Canada by Robert Goldberg, Ph.D., Washington Times, 1-12-04
- Vaccinating against disaster by Robert Goldberg, Ph.D., Washington Times, 12-17-03
Research
- "Napsterizing" Pharmaceuticals: Access, Innovation, and Consumer Welfare, NBER Working Paper No. w9229, September 2002
- U.S. Pediatric Studies Have Led to New Labeling for Nearly 100 Drugs, According to Tufts Center for the Study of Drug Development, Tufts Center for the Study of Drug Development, July 2005
- Estimating the Cost of New Drug Development: Is it Really $802 Million?, Health Affairs, March 2006
- Are Development Times for Pharmaceuticals Increasing or Decreasing?, Health Affairs, March 2006
Events
- Health for Humanity: How Patent Protection Saves Lives, Center for Medical Progress Conference, Speaker(s): Robert Goldberg, Ph.D., Julian Morris, Frank R. Lichtenberg, Roger Bate, Dr. Amir Attaran, James Love, December 2002
Transcript Available - Patents for Antiretroviral Drugs: Help or Hinder the Search for a Solution to AIDS Treatment in Africa, Center for Medical Progress Presentation, Speaker(s): Dr. Amir Attaran, Frank R. Lichtenberg, December 2001
News
- Drug companies' patents are under attack. Will this really help the poor? The Economist, 6-7-07
- Abbott Escalates Thai Patent Rift—Firm Pulls Plans to Offer New Drugs In Spat With Regime Wall Street Journal, 3-14-07
- Brazil reaches drug patent deal , 7-9-05
- Brazil aims for cheaper AIDS drugs CBSNews.com, 7-4-05
- India Adopts Patent Law Covering Pharmaceuticals International Herald Tribune, 3-24-05
- Company of the Year Biotech Behemoth Long a two-hit wonder, Amgen is on the brink of a research renaissance that will target cancer, diabetes and more. Forbes, 1-10-05
- An experiment in globalisation - how India hopes to reshape the world drugs industry - PHARMACEUTICALS: Companies hope the country can build on its success in fields such as software and become a centre for innovation and research Financial Times, 8-18-04
- Fixed-Dose Mixtures of Generic AIDS Drugs Prove Effective The New York Times, 7-15-04
- Pfizer AIDS drug has good early trial results Reuters News, 7-14-04
- Bush Seeks Policy Fix For Drug Imports The Boston Globe, 7-13-04
- Pfizer chief's speech disrupted by AIDS activists carrying mock corpses Associated Press Newswires, 7-13-04
- Generic AIDS Pill Gets Patent in Africa Wall Street Journal, 7-13-04
- U.N. Agency Drops 2 Drugs For AIDS Care Worldwide The New York Times, 6-16-04
- Vioxx Heart-Risk Evidence Mounts - Users of Merck's Painkiller Had More Hospitalizations Than Those on Celebrex Wall Street Journal, 5-28-04
- Discount Cards Still Leave Fat Markups on Generic Drugs Wall Street Journal, 5-26-04
- Genesis of a copycat generation: Despite big investment in biogeneric drugs, doubts remain about the profitability of the new industry Financial Times, 5-21-04
- Abbott AIDS drug pricing leads to review of patent Chicago Tribune, 5-21-04
- U.K. lets Zocor sell over the counter - Merck drug ruling sets stage for U.S. The Star-Ledger, 5-13-04
- Abbott Laboratories Faces Heat Over Raising Price of AIDS Drug Wall Street Journal, 5-13-04
|
|
|
Analysis and News on the Healthcare Reform Debate
NEWS
Chuck Schumer crafting public option, Politico, 7-2-09
To Fix Health Care, Some Study Developing World, Wall Street Journal, 7-2-09
COMMENTARY
Away from the Hill, in Annandale, Jim Geraghty, National Review Online, 7-2-09
'Reconciliation' to Pass Health Bill Won't Work, Mort Kondracke, RealClearPolitics.com, 7-2-09
RESEARCH
How Reforms to the Tax Treatment of Health Insurance Benefit the Middle Class, Greg D'Angelo, Rea S. Hederman, Jr., and Paul L. Winfree, The Heritage Foundation, 7-1-09
The Case for Real Health Care Reform, Joseph Antos, American Enterprise Institute, 6-30-09
MORE ON HEALTH CARE POLICY >>
|
TESTIMONY:
On Wednesday, June 24, 2009, David Gratzer, senior fellow at the Center for Medical Progress, appeared before the Ways and Means Committee
to testify about his experiences with the Canadian single-payer healthcare system.
Click here to read his statement. |
|
 |
 |
Conflict of Interest Regulation |
Consumer Driven Health Care |
Drug & Medical Device Innovation |
Drug & Medical Device Litigation |
FDA Regulation |
Global Health |
Health Care Policy |
Intellectual Property
Rights & Innovation |
Medicare and Medicaid |
Personalized Medicine |
Value of Medicine |
|
|
Paul Howard interviews J. Edward Hill, former head of the American Medical
Association, about his reaction to President Obama's speech to the American Medical Association.
Click here to listen to the podcast.
|
|
INNOVATIVE IDEAS:
Podcast Series
Stephen Parente, Academic Director, Medical Industry
Leadership Institute Carson School Of Management, Finance & Insurance, University of Minnesota, talks to Paul Howard, director of
the Center for Medical Progress, about his idea for medical banking.
Click here to listen to this podcast.
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
MPT on Twitter
MPT on Facebook
